BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1254 related articles for article (PubMed ID: 15883113)

  • 41. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
    Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
    Zárate A
    Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
    Brzezinski A; Schenker JG
    Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pitfalls of the WHIs: Women's Health Initiative.
    Mastorakos G; Sakkas EG; Xydakis AM; Creatsas G
    Ann N Y Acad Sci; 2006 Dec; 1092():331-40. PubMed ID: 17308158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hormonal replacement therapy and breast cancer].
    Noël G; Feuvret L; Gasowski M; Bernard A; Cappelaere P
    Bull Cancer; 1998 Dec; 85(12):997-1014. PubMed ID: 9917553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.
    Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P
    Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postmenopausal hormone replacement therapy and breast cancer.
    Jacobs HS
    Medscape Womens Health; 2000; 5(4):E2. PubMed ID: 11109047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progestogen use in women approaching the menopause and breast cancer risk.
    Campagnoli C; Ambroggio S; Lotano MR; Peris C
    Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk.
    Lobo RA
    Maturitas; 2005 May; 51(1):98-109. PubMed ID: 15883114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy and risk of breast cancer: the role of progestins.
    Stahlberg C; Pedersen AT; Lynge E; Ottesen B
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.